1. Proteintech. Proteintech and HebeCell announce collaboration on nanobody iPSC-derived natural killer cells (2020). www.ptglab.com/news/company-news/proteintech-and-hebecell-announce-collaboration-on-nanobody-ipsc-derived-natural-killer-cells/
2. Caribou Biosciences. Caribou Biosciences announces licensing agreement for scFvs targeting CD371 to Enable development of allogeneic cell therapies (2020). https://cariboubio.com/in-the-news/press-releases/caribou-biosciences-announces-licensing-agreement-scfvs-targeting-cd371
3. Lonza. FUJIFILM Cellular Dynamics and Lonza agree to expand the availability and use of induced pluripotent stem cell technology (2020). http://e3.marco.ch/publish/lonza/551_1332/201211_Press_Release__Lonza_FUJIFILM_expand_availability_of_IPSCs_FINAL.pdf
4. Mesoblast. Mesoblast enters global collaboration for development, manufacture and commercialization of remestemcel-L (2020). http://investorsmedia.mesoblast.com/static-files/5d4db631-9022-45ab-ad74-8db453368e5d
5. Biopharma Vor. Vor Biopharma announces exclusive license of clinical-stage CD33 CAR-T from National Cancer Institute (2020). www.vorbio.com/wp-content/uploads/2020/12/Vor-NIH-License-Nov.11-2020.pdf